Impact on Glycemic Variability After Treatment With Dapagliflozin on Type 2 Diabetes Patients
Condition: Type 2 Diabetes Intervention: Diagnostic Test: Continuous glucose monitoring Sponsors: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; AztraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Nutrition | Research